Viral Hepatitis: 1994 Update

References

• Roos B: Hepatitis epidemic conveyed by oysters. Sven Lak-Tidning 1956:53: 989.
   PubMedGoogle Scholar
• Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE: Hepatitis A in day-care centers: a community-wide assessment. N Engl J Med 1980; 302: 1222–1227.
   PubMed Web of Science ®Google Scholar
• Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G, Ryan J, Provost P, Nalin D: A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453–457.
   PubMed Web of Science ®Google Scholar
• Mao JS, Dong DX, Zhang SY, Zhang HY, Chen NL, Huang HY, Xie RY, Chai CA, Zhou TJ, Wu DM, Zhang HC: Further studies of attenuated live hepatitis A vaccine (H2 strain) in humans. In Hollinger FB, Lemon ST, Margolis H, eds: Viral hepatitis in liver disease. Baltimore: Williams and Wilkins, 1991: 110–111.
   Google Scholar
• Gluck R, Mischler R, Brantschen S, Just M, Althaus B, Cryz SJ Jr: Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A. J Clin Invest 1992; 90: 2491–2495.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE: Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599–603.
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB: Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981; 94: 744–748.
   PubMed Web of Science ®Google Scholar
• Peters M: Mechanisms of action of interferons. Semin Liver Dis 1989; 9: 235–239.
   PubMed Web of Science ®Google Scholar
• Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, The Hepatitis Interventional Therapy Group: A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295–301.
   Web of Science ®Google Scholar
• Brook MG, Karayiannis P, Thomas HC: Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors. Hepatology 1989; 10: 761–763.
   PubMed Web of Science ®Google Scholar
• Perrillo RD: Factors influencing response to interferon in chronic hepatitis B: implications for Asian and western populations [editorial]. Hepatology 1990; 12: 1433–1435.
   Web of Science ®Google Scholar
• Renault PF, HoofnagleJH: Side effects of alpha-interferon. Semin Liver Dis 1989; 9: 273–277.
   PubMed Web of Science ®Google Scholar
• Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE: Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease. Hepatology 1991; 13: 619–626.
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y: Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993; 104: 1116–1121.
   PubMed Web of Science ®Google Scholar
• Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H, and the Investigators of the European Concerted Action on Viral Hepatitis Study: Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842–1847.
   Web of Science ®Google Scholar
• Authors Anonymous: Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morb Mortal Wkly Rep 1991; 40: 1–25.
   Google Scholar
• Stevens CE, Taylor PE, Pindyck J, Choo QL, Bradley DW, Kuo G, Houghton M: Epidemiology of hepatitis C virus: a preliminary study in volunteer blood donors. JAMA 1990; 263: 49–53.
   PubMed Web of Science ®Google Scholar
• Wang JT, Wang TH, Sheu JC, Lin JT, Chen DS: Hepatitis C virus RNA in saliva of patients with posttransfusion hepatitis and low efficiency of transmission among spouses. J Med Virol 1992; 36: 28–31.
   PubMed Web of Science ®Google Scholar
• Rosenthal P: Does maternal-neonatal transmission of hepatitis C occur—are we sure? Am J Gastroenterol 1993; 88: 1284–1286.
   PubMedGoogle Scholar
• Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, The Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501–1506.
   Web of Science ®Google Scholar
• Realdi G, Diodati G, Bonetti P, Scaccabarozzi S, Alberti A, Ruol A: Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis: preliminary results of a randomized, controlled trial. J Hepatol 1990; 11 (1 Suppl): 68S–71S.
   Web of Science ®Google Scholar
• Liang TJ, Jeffers LJ, Reddy R, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993; 18: 1326–1333.
   PubMed Web of Science ®Google Scholar
• Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL, Greenberg HB: Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317–322.
   PubMed Web of Science ®Google Scholar
• O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, Alexander GJ, Williams R: Hepatitis B virus reinfection after orthotopic liver transplantation: serological and clinical implications. J Hepatol 1992; 14: 104–111.
   PubMed Web of Science ®Google Scholar